Sinovac Biotech Seeks To Expand Use Of COVID-19 Vaccine On Ages 3 To 17 — FDA
Sinovac Biotech sought to expand the use of its COVID-19 vaccine on children ages 3 to 17, according to FDA. The Food and Drug Administration (FDA) said that Sinovac Biotech sought to expand the use of its COVID-19 vaccine on children ages 3 to 17. During the Cabinet briefing aired early Wednesday, FDA Director-General Eric … Read more